seed
Stage
2019
Founded
2
Investors
About
EndLyz Therapeutics is a UK-based biotech company developing novel therapeutics for the treatment of neurodegenerative diseases. They focus on conditions such as Alzheimer's, Parkinson's, and Huntington's diseases.
Explore EndLyz Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.